id CRUZ_956a374b10cbfef3ad6b9de7f8e21322
oai_identifier_str oai:www.arca.fiocruz.br:icict/23739
network_acronym_str CRUZ
network_name_str Repositório Institucional da FIOCRUZ (ARCA)
repository_id_str 2135
spelling Fogel, Jessica M.Hudelson, Sarah E.Ou, San-SanHart, StephenWallis, CaroleMorgado, Mariza G.Saravanan, ShanmugamTripathy, SrikanthHovind, LauraPiwowar-Manning, EstelleSabin, DevinMcCauley, MarybethGamble, TheresaZhang, Xinyi C.Eron, Joseph J.Gallant, Joel E.Kumwenda, JohnstoneMakhema, JosephKumarasamy, NagalingeswaranChariyalertsak, SuwatHakim, JamesBadal-Faesen, SharlaaAkelo, VictorHosseinipour, Mina C.Santos, Breno R.Godbole, Sheela V.Pilotto, Jose H.Grinsztejn, BeatrizPanchia, RavindreMayer, Kenneth H.Chen, Ying Q.Cohen, Myron S.Eshleman, Susan H.2017-12-21T13:02:47Z2017-12-21T13:02:47Z2016FOGEL, Jessica M. et al. HIV drug resistance in adults failing early antiretroviral treatment: results from the HIV Prevention Trials Network 052 trial. Acquir Immune Defic Syndr. v.72, n.3, p.304–309, July 2016.1525-4135https://www.arca.fiocruz.br/handle/icict/2373910.1097/QAI.00000000000009511944-7884engLippincott, Williams & WilkinsHIVResistênciaTerapia AntirretroviralHPTN 052Antiretroviral TherapyART failureresistanceBrief Report: HIV Drug Resistance in Adults Failing Early Antiretroviral Treatment: Results From the HIV Prevention Trials Network 052 Trialinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleJohns Hopkins Univ. School of Medicine. Dept. of Pathology. Baltimore, Maryland, USA.Johns Hopkins Univ. School of Medicine. Dept. of Pathology. Baltimore, Maryland, USA.Fred Hutchinson Cancer Research Center. Vaccine and Infectious Disease Division. Seattle, VA, USA.Frontier Science & Technology Research Foundation. Amherst, NY, USA.Lancet Laboratories and BARC-SA. Specialty Molecular Division. Johannesburg, South Africa.Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de AIDS e Imunologia Molecular. Rio de Janeiro, RJ. Brasil.Y. R. Gaitonade Centre for AIDS Research and Education. Chennai, India.National JALMA Institute for Leprosy and Other Mycobacterial Diseases. Agra, India.Frontier Science & Technology Research Foundation. Amherst, NY, USA.Johns Hopkins Univ. School of Medicine. Dept. of Pathology. Baltimore, MD, USA.Johns Hopkins Univ. School of Medicine. Dept. of Pathology. Baltimore, MD, USA.Science Facilitation Department. FHI 360. Washington, DC, USA.Science Facilitation Department. FHI 360, Durham, NC, USA.Fred Hutchinson Cancer Research Center. Vaccine and Infectious Disease Division. Seattle, WA, USA.Univ. of North Carolina at Chapel Hill. Dept. of Medicine. Chapel Hill, NC, USA.Southwest CARE Center. Santa Fe, NM, USA.College of Medicine. Johns Hopkins Project. Blantyre, Malawi.Botswana Harvard AIDS Institute. Gaborone, Botswana.YRGCARE Medical Centre.VHS. Chennai, India.Chiang Mai University. Research Institute for Health Sciences. Chiang Mai, Thailand.University of Zimbabwe. Dept. of Medicine. Harare, Zimbabwe.Univ. of Witwatersrand. Johannesburg, South Africa.Kenya Medical Research Institute. Kisumu, Kenya. / Center for Disease Control. Kisumu, Kenya.Univ. of North Carolina at Chapel Hill. Division of Infectious Diseases. Chapel Hill, NC, USA / UNC Project-Malawi. Institute for Global Health and Infectious Diseases. Lilongwe, Malawi.Hospital Nossa Senhora da Conceição. Serviço de Infectologia. Porto Alegre, RS, Brasil.National AIDS Research Institute (ICMR). Pune, India.Hospital Geral de Nova Iguacu. Nova Iguaçu, RJ, Brasil / Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de AIDS e Imunologia Molecular. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.University of the Witwatersrand. Perinatal HIV Research Unit. Soweto, South Africa.The Fenway Institute. Fenway Health and Infectious Disease Division. Boston, MA, USA / Harvard Medical School. Beth Israel Deaconess Medical Center/Dept. of Medicine. Boston, MA, USA.Fred Hutchinson Cancer Research Center. Vaccine and Infectious Disease Division and Public Health Sciences Division. Seattle, VA, USA.Univ. of North Carolina at Chapel Hill. Department of Medicine. Chapel Hill, NC, USA.Univ. of North Carolina at Chapel Hill. Dept. of Pathology. Baltimore, MD, USA.Early initiation of antiretroviral treatment (ART) reduces HIV transmission and has health benefits. HIV drug resistance can limit treatment options and compromise use of ART for HIV prevention. We evaluated drug resistance in 85 participants in the HIV Prevention Trials Network 052 trial who started ART at CD4 counts of 350-550 cells per cubic millimeter and failed ART by May 2011; 8.2% had baseline resistance and 35.3% had resistance at ART failure. High baseline viral load and less education were associated with emergence of resistance at ART failure. Resistance at ART failure was observed in 7 of 8 (87.5%) participants who started ART at lower CD4 cell counts.info:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-82991https://www.arca.fiocruz.br/bitstream/icict/23739/1/license.txt5a560609d32a3863062d77ff32785d58MD51ORIGINALmariza_morgado_etal_IOC_2016.pdfmariza_morgado_etal_IOC_2016.pdfapplication/pdf137842https://www.arca.fiocruz.br/bitstream/icict/23739/2/mariza_morgado_etal_IOC_2016.pdf9c34307109b7b6cd29edde12809a3008MD52TEXTmariza_morgado_etal_IOC_2016.pdf.txtmariza_morgado_etal_IOC_2016.pdf.txtExtracted texttext/plain35785https://www.arca.fiocruz.br/bitstream/icict/23739/3/mariza_morgado_etal_IOC_2016.pdf.txte54a755296e3f29967fa75d082051f37MD53icict/237392018-08-15 02:54:42.377oai:www.arca.fiocruz.br:icict/23739Q0VTU8ODTyBOw4NPIEVYQ0xVU0lWQSBERSBESVJFSVRPUyBBVVRPUkFJUwoKQW8gYWNlaXRhciBvcyBURVJNT1MgZSBDT05EScOHw5VFUyBkZXN0YSBDRVNTw4NPLCBvIEFVVE9SIGUvb3UgVElUVUxBUiBkZSBkaXJlaXRvcwphdXRvcmFpcyBzb2JyZSBhIE9CUkEgZGUgcXVlIHRyYXRhIGVzdGUgZG9jdW1lbnRvOgoKKDEpIENFREUgZSBUUkFOU0ZFUkUsIHRvdGFsIGUgZ3JhdHVpdGFtZW50ZSwgw6AgRklPQ1JVWiAtIEZVTkRBw4fDg08gT1NXQUxETyBDUlVaLCBlbQpjYXLDoXRlciBwZXJtYW5lbnRlLCBpcnJldm9nw6F2ZWwgZSBOw4NPIEVYQ0xVU0lWTywgdG9kb3Mgb3MgZGlyZWl0b3MgcGF0cmltb25pYWlzIE7Dg08KQ09NRVJDSUFJUyBkZSB1dGlsaXphw6fDo28gZGEgT0JSQSBhcnTDrXN0aWNhIGUvb3UgY2llbnTDrWZpY2EgaW5kaWNhZGEgYWNpbWEsIGluY2x1c2l2ZSBvcyBkaXJlaXRvcwpkZSB2b3ogZSBpbWFnZW0gdmluY3VsYWRvcyDDoCBPQlJBLCBkdXJhbnRlIHRvZG8gbyBwcmF6byBkZSBkdXJhw6fDo28gZG9zIGRpcmVpdG9zIGF1dG9yYWlzLCBlbQpxdWFscXVlciBpZGlvbWEgZSBlbSB0b2RvcyBvcyBwYcOtc2VzOwoKKDIpIEFDRUlUQSBxdWUgYSBjZXNzw6NvIHRvdGFsIG7Do28gZXhjbHVzaXZhLCBwZXJtYW5lbnRlIGUgaXJyZXZvZ8OhdmVsIGRvcyBkaXJlaXRvcyBhdXRvcmFpcwpwYXRyaW1vbmlhaXMgbsOjbyBjb21lcmNpYWlzIGRlIHV0aWxpemHDp8OjbyBkZSBxdWUgdHJhdGEgZXN0ZSBkb2N1bWVudG8gaW5jbHVpLCBleGVtcGxpZmljYXRpdmFtZW50ZSwKb3MgZGlyZWl0b3MgZGUgZGlzcG9uaWJpbGl6YcOnw6NvIGUgY29tdW5pY2HDp8OjbyBww7pibGljYSBkYSBPQlJBLCBlbSBxdWFscXVlciBtZWlvIG91IHZlw61jdWxvLAppbmNsdXNpdmUgZW0gUmVwb3NpdMOzcmlvcyBEaWdpdGFpcywgYmVtIGNvbW8gb3MgZGlyZWl0b3MgZGUgcmVwcm9kdcOnw6NvLCBleGliacOnw6NvLCBleGVjdcOnw6NvLApkZWNsYW1hw6fDo28sIHJlY2l0YcOnw6NvLCBleHBvc2nDp8OjbywgYXJxdWl2YW1lbnRvLCBpbmNsdXPDo28gZW0gYmFuY28gZGUgZGFkb3MsIHByZXNlcnZhw6fDo28sIGRpZnVzw6NvLApkaXN0cmlidWnDp8OjbywgZGl2dWxnYcOnw6NvLCBlbXByw6lzdGltbywgdHJhZHXDp8OjbywgZHVibGFnZW0sIGxlZ2VuZGFnZW0sIGluY2x1c8OjbyBlbSBub3ZhcyBvYnJhcyBvdQpjb2xldMOibmVhcywgcmV1dGlsaXphw6fDo28sIGVkacOnw6NvLCBwcm9kdcOnw6NvIGRlIG1hdGVyaWFsIGRpZMOhdGljbyBlIGN1cnNvcyBvdSBxdWFscXVlciBmb3JtYSBkZQp1dGlsaXphw6fDo28gbsOjbyBjb21lcmNpYWw7CgooMykgUkVDT05IRUNFIHF1ZSBhIGNlc3PDo28gYXF1aSBlc3BlY2lmaWNhZGEgY29uY2VkZSDDoCBGSU9DUlVaIC0gRlVOREHDh8ODTyBPU1dBTERPCkNSVVogbyBkaXJlaXRvIGRlIGF1dG9yaXphciBxdWFscXVlciBwZXNzb2Eg4oCTIGbDrXNpY2Egb3UganVyw61kaWNhLCBww7pibGljYSBvdSBwcml2YWRhLCBuYWNpb25hbCBvdQplc3RyYW5nZWlyYSDigJMgYSBhY2Vzc2FyIGUgdXRpbGl6YXIgYW1wbGFtZW50ZSBhIE9CUkEsIHNlbSBleGNsdXNpdmlkYWRlLCBwYXJhIHF1YWlzcXVlcgpmaW5hbGlkYWRlcyBuw6NvIGNvbWVyY2lhaXM7CgooNCkgREVDTEFSQSBxdWUgYSBvYnJhIMOpIGNyaWHDp8OjbyBvcmlnaW5hbCBlIHF1ZSDDqSBvIHRpdHVsYXIgZG9zIGRpcmVpdG9zIGFxdWkgY2VkaWRvcyBlIGF1dG9yaXphZG9zLApyZXNwb25zYWJpbGl6YW5kby1zZSBpbnRlZ3JhbG1lbnRlIHBlbG8gY29udGXDumRvIGUgb3V0cm9zIGVsZW1lbnRvcyBxdWUgZmF6ZW0gcGFydGUgZGEgT0JSQSwKaW5jbHVzaXZlIG9zIGRpcmVpdG9zIGRlIHZveiBlIGltYWdlbSB2aW5jdWxhZG9zIMOgIE9CUkEsIG9icmlnYW5kby1zZSBhIGluZGVuaXphciB0ZXJjZWlyb3MgcG9yCmRhbm9zLCBiZW0gY29tbyBpbmRlbml6YXIgZSByZXNzYXJjaXIgYSBGSU9DUlVaIC0gRlVOREHDh8ODTyBPU1dBTERPIENSVVogZGUKZXZlbnR1YWlzIGRlc3Blc2FzIHF1ZSB2aWVyZW0gYSBzdXBvcnRhciwgZW0gcmF6w6NvIGRlIHF1YWxxdWVyIG9mZW5zYSBhIGRpcmVpdG9zIGF1dG9yYWlzIG91CmRpcmVpdG9zIGRlIHZveiBvdSBpbWFnZW0sIHByaW5jaXBhbG1lbnRlIG5vIHF1ZSBkaXogcmVzcGVpdG8gYSBwbMOhZ2lvIGUgdmlvbGHDp8O1ZXMgZGUgZGlyZWl0b3M7CgooNSkgQUZJUk1BIHF1ZSBjb25oZWNlIGEgUG9sw610aWNhIEluc3RpdHVjaW9uYWwgZGUgQWNlc3NvIEFiZXJ0byBkYSBGSU9DUlVaIC0gRlVOREHDh8ODTwpPU1dBTERPIENSVVogZSBhcyBkaXJldHJpemVzIHBhcmEgbyBmdW5jaW9uYW1lbnRvIGRvIHJlcG9zaXTDs3JpbyBpbnN0aXR1Y2lvbmFsIEFSQ0EuCgpBIFBvbMOtdGljYSBJbnN0aXR1Y2lvbmFsIGRlIEFjZXNzbyBBYmVydG8gZGEgRklPQ1JVWiAtIEZVTkRBw4fDg08gT1NXQUxETyBDUlVaIHJlc2VydmEKZXhjbHVzaXZhbWVudGUgYW8gQVVUT1Igb3MgZGlyZWl0b3MgbW9yYWlzIGUgb3MgdXNvcyBjb21lcmNpYWlzIHNvYnJlIGFzIG9icmFzIGRlIHN1YSBhdXRvcmlhCmUvb3UgdGl0dWxhcmlkYWRlLCBzZW5kbyBvcyB0ZXJjZWlyb3MgdXN1w6FyaW9zIHJlc3BvbnPDoXZlaXMgcGVsYSBhdHJpYnVpw6fDo28gZGUgYXV0b3JpYSBlIG1hbnV0ZW7Dp8OjbwpkYSBpbnRlZ3JpZGFkZSBkYSBPQlJBIGVtIHF1YWxxdWVyIHV0aWxpemHDp8Ojby4KCkEgUG9sw610aWNhIEluc3RpdHVjaW9uYWwgZGUgQWNlc3NvIEFiZXJ0byBkYSBGSU9DUlVaIC0gRlVOREHDh8ODTyBPU1dBTERPIENSVVoKcmVzcGVpdGEgb3MgY29udHJhdG9zIGUgYWNvcmRvcyBwcmVleGlzdGVudGVzIGRvcyBBdXRvcmVzIGNvbSB0ZXJjZWlyb3MsIGNhYmVuZG8gYW9zIEF1dG9yZXMKaW5mb3JtYXIgw6AgSW5zdGl0dWnDp8OjbyBhcyBjb25kacOnw7VlcyBlIG91dHJhcyByZXN0cmnDp8O1ZXMgaW1wb3N0YXMgcG9yIGVzdGVzIGluc3RydW1lbnRvcy4KRepositório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352018-08-15T05:54:42Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false
dc.title.pt_BR.fl_str_mv Brief Report: HIV Drug Resistance in Adults Failing Early Antiretroviral Treatment: Results From the HIV Prevention Trials Network 052 Trial
title Brief Report: HIV Drug Resistance in Adults Failing Early Antiretroviral Treatment: Results From the HIV Prevention Trials Network 052 Trial
spellingShingle Brief Report: HIV Drug Resistance in Adults Failing Early Antiretroviral Treatment: Results From the HIV Prevention Trials Network 052 Trial
Fogel, Jessica M.
HIV
Resistência
Terapia Antirretroviral
HPTN 052
Antiretroviral Therapy
ART failure
resistance
title_short Brief Report: HIV Drug Resistance in Adults Failing Early Antiretroviral Treatment: Results From the HIV Prevention Trials Network 052 Trial
title_full Brief Report: HIV Drug Resistance in Adults Failing Early Antiretroviral Treatment: Results From the HIV Prevention Trials Network 052 Trial
title_fullStr Brief Report: HIV Drug Resistance in Adults Failing Early Antiretroviral Treatment: Results From the HIV Prevention Trials Network 052 Trial
title_full_unstemmed Brief Report: HIV Drug Resistance in Adults Failing Early Antiretroviral Treatment: Results From the HIV Prevention Trials Network 052 Trial
title_sort Brief Report: HIV Drug Resistance in Adults Failing Early Antiretroviral Treatment: Results From the HIV Prevention Trials Network 052 Trial
author Fogel, Jessica M.
author_facet Fogel, Jessica M.
Hudelson, Sarah E.
Ou, San-San
Hart, Stephen
Wallis, Carole
Morgado, Mariza G.
Saravanan, Shanmugam
Tripathy, Srikanth
Hovind, Laura
Piwowar-Manning, Estelle
Sabin, Devin
McCauley, Marybeth
Gamble, Theresa
Zhang, Xinyi C.
Eron, Joseph J.
Gallant, Joel E.
Kumwenda, Johnstone
Makhema, Joseph
Kumarasamy, Nagalingeswaran
Chariyalertsak, Suwat
Hakim, James
Badal-Faesen, Sharlaa
Akelo, Victor
Hosseinipour, Mina C.
Santos, Breno R.
Godbole, Sheela V.
Pilotto, Jose H.
Grinsztejn, Beatriz
Panchia, Ravindre
Mayer, Kenneth H.
Chen, Ying Q.
Cohen, Myron S.
Eshleman, Susan H.
author_role author
author2 Hudelson, Sarah E.
Ou, San-San
Hart, Stephen
Wallis, Carole
Morgado, Mariza G.
Saravanan, Shanmugam
Tripathy, Srikanth
Hovind, Laura
Piwowar-Manning, Estelle
Sabin, Devin
McCauley, Marybeth
Gamble, Theresa
Zhang, Xinyi C.
Eron, Joseph J.
Gallant, Joel E.
Kumwenda, Johnstone
Makhema, Joseph
Kumarasamy, Nagalingeswaran
Chariyalertsak, Suwat
Hakim, James
Badal-Faesen, Sharlaa
Akelo, Victor
Hosseinipour, Mina C.
Santos, Breno R.
Godbole, Sheela V.
Pilotto, Jose H.
Grinsztejn, Beatriz
Panchia, Ravindre
Mayer, Kenneth H.
Chen, Ying Q.
Cohen, Myron S.
Eshleman, Susan H.
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Fogel, Jessica M.
Hudelson, Sarah E.
Ou, San-San
Hart, Stephen
Wallis, Carole
Morgado, Mariza G.
Saravanan, Shanmugam
Tripathy, Srikanth
Hovind, Laura
Piwowar-Manning, Estelle
Sabin, Devin
McCauley, Marybeth
Gamble, Theresa
Zhang, Xinyi C.
Eron, Joseph J.
Gallant, Joel E.
Kumwenda, Johnstone
Makhema, Joseph
Kumarasamy, Nagalingeswaran
Chariyalertsak, Suwat
Hakim, James
Badal-Faesen, Sharlaa
Akelo, Victor
Hosseinipour, Mina C.
Santos, Breno R.
Godbole, Sheela V.
Pilotto, Jose H.
Grinsztejn, Beatriz
Panchia, Ravindre
Mayer, Kenneth H.
Chen, Ying Q.
Cohen, Myron S.
Eshleman, Susan H.
dc.subject.other.pt_BR.fl_str_mv HIV
Resistência
Terapia Antirretroviral
topic HIV
Resistência
Terapia Antirretroviral
HPTN 052
Antiretroviral Therapy
ART failure
resistance
dc.subject.en.pt_BR.fl_str_mv HPTN 052
Antiretroviral Therapy
ART failure
resistance
description Johns Hopkins Univ. School of Medicine. Dept. of Pathology. Baltimore, Maryland, USA.
publishDate 2016
dc.date.issued.fl_str_mv 2016
dc.date.accessioned.fl_str_mv 2017-12-21T13:02:47Z
dc.date.available.fl_str_mv 2017-12-21T13:02:47Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv FOGEL, Jessica M. et al. HIV drug resistance in adults failing early antiretroviral treatment: results from the HIV Prevention Trials Network 052 trial. Acquir Immune Defic Syndr. v.72, n.3, p.304–309, July 2016.
dc.identifier.uri.fl_str_mv https://www.arca.fiocruz.br/handle/icict/23739
dc.identifier.issn.pt_BR.fl_str_mv 1525-4135
dc.identifier.doi.none.fl_str_mv 10.1097/QAI.0000000000000951
dc.identifier.eissn.none.fl_str_mv 1944-7884
identifier_str_mv FOGEL, Jessica M. et al. HIV drug resistance in adults failing early antiretroviral treatment: results from the HIV Prevention Trials Network 052 trial. Acquir Immune Defic Syndr. v.72, n.3, p.304–309, July 2016.
1525-4135
10.1097/QAI.0000000000000951
1944-7884
url https://www.arca.fiocruz.br/handle/icict/23739
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Lippincott, Williams & Wilkins
publisher.none.fl_str_mv Lippincott, Williams & Wilkins
dc.source.none.fl_str_mv reponame:Repositório Institucional da FIOCRUZ (ARCA)
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Repositório Institucional da FIOCRUZ (ARCA)
collection Repositório Institucional da FIOCRUZ (ARCA)
bitstream.url.fl_str_mv https://www.arca.fiocruz.br/bitstream/icict/23739/1/license.txt
https://www.arca.fiocruz.br/bitstream/icict/23739/2/mariza_morgado_etal_IOC_2016.pdf
https://www.arca.fiocruz.br/bitstream/icict/23739/3/mariza_morgado_etal_IOC_2016.pdf.txt
bitstream.checksum.fl_str_mv 5a560609d32a3863062d77ff32785d58
9c34307109b7b6cd29edde12809a3008
e54a755296e3f29967fa75d082051f37
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv repositorio.arca@fiocruz.br
_version_ 1798324764916318208